登录新浪财经APP 搜索【信披】查看更多考评等级 第三季度财务报表是否经审计 □是√否 一、主要财务数据 证券代码：601399 证券简称：国机重装 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误导性陈 述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息的真 实、准确、完整。 （一）主要会计数据和财务指标 单位：元币种：人民币 ■ 注："本报告期"指本季度初至本季度末3个月期间，下同。 （二）非经常性损益项目和金额 √适用 □不适用 单位:元币种:人民币 ■ 对公司将《公开发行证券的公司信息披露解释性公告第1号一一非经常性损益》未列举的项目认定为非 经常性损益项目且金额重大的，以及将《公开发行证券的公司信息披露解释性公告第1号一一非经常性 损益》中列举的非经常性损益项目界定为经常性损益的项目，应说明原因。 □适用 √不适用 □适用 √不适用 前10名 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002783 证券简称：凯龙股份 公告编号：2025-074 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 ■ （二） 非经常性损益项目和金额 √适用 □不适用 单位：元 ■ 一、主要财务数据 3.第三季度财务会计报告是否经过审计 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 √否 □是 √否 其他符合非经常性损益定义的损益项目的具体情况： □适用 √不适用 公司不存在其他符合非经常性损益定义的损益项目的具体情况。 将《公开发行证券的公司信息披露解释性公告第1号一一非经常性损益》中列举的非经常性损益项目界 定为经常性损益项目的情况说明 □适用 √不适用 公司不存在将《公开发行证券的公司信息披露解释性公告第 ...

Core Points - The annual compliance review for Nasdaq-listed companies is crucial for ensuring adherence to listing rules, SEC regulations, and maintaining investor trust [2] - The review focuses on the authenticity of financial reports, effectiveness of corporate governance, compliance with information disclosure, and soundness of internal controls [2] Financial Reporting and Audit Compliance - Nasdaq requires companies to submit independently audited annual reports (Form 10-K), emphasizing the authenticity and transparency of financial statements [2] - Key areas of focus include financial statement audits, compliance with the Sarbanes-Oxley Act (SOX), and consistency of financial data [3] Corporate Governance and Board Compliance - Nasdaq rules impose strict requirements on corporate governance, with annual reviews focusing on board composition and independence, executive compensation, and shareholder rights [2][3] - The majority of board members must be independent, and the audit committee must consist entirely of independent directors, with at least one possessing financial expertise [3] Information Disclosure and Transparency - Nasdaq emphasizes timely, accurate, and complete information disclosure, with annual reviews covering annual reports (Form 10-K) and proxy statements [4] - Companies must ensure timely submission of Form 8-K for significant events, avoiding delays or omissions [4] Internal Control and Risk Management - The annual review assesses the overall risk management framework, including key business process controls and risk management policies [6] - Companies must disclose major risks and their mitigation strategies, with auditors evaluating management's ability to identify and respond to risks [7] Listing Rules and Ongoing Compliance - Nasdaq maintains strict ongoing listing requirements, with annual reviews verifying compliance with listing standards and other obligations [6] - Companies must ensure compliance with regulations such as anti-money laundering (AML) and data privacy laws [7] Special Considerations for Certain Company Types - Foreign Private Issuers can use IFRS for financial reporting but must disclose differences from US GAAP [7] - Emerging Growth Companies may simplify certain disclosures but must still meet basic financial and governance requirements [7]

Core Viewpoint - The company has undergone significant changes in its shareholder structure and management, while also planning to continue its financial support to subsidiaries and maintain its auditing arrangements for the upcoming year [7][11][54]. Group 1: Company Overview - The company is named Shenzhen Lihe Science and Technology Co., Ltd. and is listed under the stock code 002243 [1]. - The company has not changed its controlling shareholder or actual controller during the reporting period [4][5]. Group 2: Financial and Operational Updates - The company plans not to distribute cash dividends or issue bonus shares for the reporting period [2]. - The company issued a total of RMB 700 million in medium-term notes with an interest rate of 2.18% [9]. - The company approved a financial assistance plan to provide up to RMB 640 million to its wholly-owned subsidiary Guangzhou Lihe Science and Technology Center [22]. Group 3: Shareholder Structure Changes - The company announced a change in the upper shareholder structure of its controlling shareholder, Shenzhen Qingyan Investment Holdings Co., Ltd., which was transferred to the Shenzhen Municipal Government State-owned Assets Supervision and Administration Commission [7][10]. - The transfer of 100% equity of the controlling shareholder was completed without affecting the company's governance structure [11]. Group 4: Management Changes - The company appointed Xu Anbi as the new general manager after the resignation of He Zhen, who will continue as chairman [8][12]. - The company also elected Yang Gaoyu as an independent director following the resignation of Zhang Hanbin [12]. Group 5: Audit and Compliance - The company has proposed to continue using the auditing services of Deloitte Touche Tohmatsu Certified Public Accountants for the year 2025, with an expected audit fee of RMB 1.7 million [54][55]. - The audit committee and supervisory board have reviewed and approved the decision to retain the auditing firm, ensuring compliance with relevant regulations [66].

Meeting Details - The 19th meeting of the third Supervisory Board of Jiangsu Haoaobo Biopharmaceutical Co., Ltd. was held on August 13, 2025, with all three supervisors present [1] - The meeting was convened in accordance with the Company Law of the People's Republic of China and the company's articles of association, ensuring the legality and validity of the resolutions [1] Financial Report Review - The Supervisory Board reviewed the company's 2025 semi-annual report, confirming that its preparation and review procedures comply with relevant laws and internal management regulations [1] - The report accurately reflects the company's financial status and operating results for the first half of 2025, with all members of the Supervisory Board ensuring the information disclosed is true, accurate, and complete [1] Fund Management - The Supervisory Board assessed the management of raised funds, confirming compliance with the regulations governing the management of raised funds and the company's fundraising management system [2] - The company has stored and utilized the raised funds in a dedicated account, with no violations or damages to the interests of the company and its shareholders [2] Auditor Appointment - The Supervisory Board approved the appointment of Ernst & Young Hua Ming LLP as the auditing firm for the company's 2025 financial report and internal control audit, citing their qualifications and experience [3] - The resolution received unanimous approval from all supervisors, with 100% of the voting rights in favor [3]

Group 1 - The company is holding its second extraordinary general meeting of shareholders for 2025 on July 31, 2025, at 14:30, located at the Qulian Industrial Park, Hangzhou [5][6] - Shareholders and their representatives must register for the meeting by providing identification and relevant authorization documents, and only registered participants can vote [2][3] - The voting process will combine on-site and online voting, with each share granting one vote, and improper ballots will be considered as abstentions [3][5] Group 2 - The company proposes to reappoint Rongcheng Certified Public Accountants (Special General Partnership) as the auditing firm for the 2025 financial report and internal control, with an audit fee of 750,000 RMB [7][8] - Rongcheng Certified Public Accountants has a long history in the industry, originally established in 1988, and has been involved in auditing for numerous listed companies [8][9] - The auditing firm has been involved in 518 listed companies' annual report audits in 2024, with a total audit fee of approximately 620 million RMB [9]

Core Viewpoint - The company, Qingdao Inpace Health Technology Co., Ltd., has announced the reappointment of Heshin Accounting Firm as its auditor for the year 2025, ensuring the continuity of its auditing services and compliance with regulatory requirements [9][10][19]. Financial Data - The first quarter report for the company has not been audited [8]. - The company has repurchased 1,256,700 shares, accounting for 0.85% of the total share capital as of the reporting period [5]. Shareholder Information - The company has confirmed that there are no changes in the major shareholders and their shareholding status compared to the previous period [6]. Audit Firm Information - Heshin Accounting Firm has been selected for reappointment, with an audit fee of 850,000 yuan and an internal control audit fee of 280,000 yuan, remaining the same as the previous year [10][17]. - The firm has a total of 45 partners and 254 registered accountants, with 139 of them having signed audit reports for securities services [11]. - The firm has not faced any criminal penalties or disciplinary actions in the last three years [13][15]. Audit Committee and Board Decisions - The audit committee has reviewed and approved the reappointment of Heshin Accounting Firm, emphasizing its qualifications and independence [18]. - The board of directors unanimously approved the proposal to reappoint the audit firm, which will be subject to shareholder approval [19].

Group 1 - The audit committee of Zhejiang Changcheng Electric Technology Co., Ltd. consists of three members, including independent directors and a board member, with the chairman being a qualified independent director [1][3] - The audit committee held multiple meetings during the reporting period, approving key documents such as the 2023 annual report, financial settlement report, and internal control evaluation report [1][2] - The committee actively communicated with Tianjian Accounting Firm to establish the audit plan for the 2024 financial report and ensured the audit was completed smoothly [3][4] Group 2 - The audit committee reviewed quarterly, semi-annual, and annual financial reports, confirming no significant accounting errors or fraud related to financial reporting [3][4] - The financial reports were prepared in accordance with accounting standards and reflected the company's financial status, operating results, and cash flow accurately [4] - The committee emphasized the importance of internal control systems and provided guidance for their implementation, ensuring they align with the company's scale, business scope, and risk levels [4][5] Group 3 - The audit committee effectively supervised external audits and guided internal audit work, ensuring the accuracy and completeness of financial reports [5] - The committee plans to continue enhancing its supervisory functions, focusing on internal control systems, audit quality, and risk management [5]